Plain-English translation of NCT05343013 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Colorectal Cancer research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is studying a medication called to help colorectal cancer patients who have finished chemotherapy but show early warning signs (detected through a blood test) that cancer might return. The study will test whether taking this medication by mouth twice a day for 6 months can clear these early warning signs and prevent the cancer from coming back. Researchers will measure how well the treatment works and monitor for any side effects.
Even after successful chemotherapy and surgery, some colorectal cancer patients show early signs of cancer recurrence detectable only through specialized blood tests before any tumors are visible on imaging. This trial exists to see whether treating patients at this very early stage with the medication can prevent full cancer recurrence and improve long-term survival.
You likely qualify if…
You likely don't qualify if…
You would take the medication by mouth twice a day (morning and evening, with meals) for 6 months. The study involves regular blood tests to check for cancer markers and monitor your organ function, as well as assessments by the research team. You would need to visit the clinic for monitoring during treatment and commit to using contraception during the 6-month treatment period and for 7 months after stopping the medication.
AI-generated summary from trial data · Aug 11, 2026 · Not medical advice
United States